Jeffrey T. Walsh

2018

In 2018, Jeffrey T. Walsh earned a total compensation of $9.3M as Chief Strategy Officer at bluebird bio, a 93% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$234,900
Option Awards$6,269,843
Salary$450,000
Stock Awards$2,309,063
Other$12,250
Total$9,276,056

Walsh received $6.3M in option awards, accounting for 68% of the total pay in 2018.

Walsh also received $234.9K in non-equity incentive plan, $450K in salary, $2.3M in stock awards and $12.3K in other compensation.

Rankings

In 2018, Jeffrey T. Walsh's compensation ranked 789th out of 14,244 executives tracked by ExecPay. In other words, Walsh earned more than 94.5% of executives.

ClassificationRankingPercentile
All
789
out of 14,244
95th
Division
Manufacturing
262
out of 5,758
95th
Major group
Chemicals And Allied Products
76
out of 2,119
96th
Industry group
Drugs
59
out of 1,808
97th
Industry
Biological Products, Except Diagnostic Substances
17
out of 339
95th
Source: SEC filing on April 23, 2019.

Walsh's colleagues

We found four more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2018.

2018

Nick Leschly

bluebird bio

Chief Executive Officer

2018

David Davidson

bluebird bio

Chief Medical Officer

2018

Philip Gregory

bluebird bio

Chief Scientific Officer

2018

Jason Cole

bluebird bio

Chief Operating and Legal Officer

News

In-depth

You may also like